Please log in to view this page
Username
Password
A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...
The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...
P1078 is a Phase IV, randomized, double-blind, placebo-controlled study of HIV-infected pregnant women and the infants born to...
1077BF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
A single dose of nevirapine (SD NVP) given to an HIV infected pregnant woman followed by a single dose to her infant has been...
